AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05972122 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Analgesia management; group S and C
Description: Patients will be administered ibuprofen 400 mgr IV every 8 hours in the postoperative period. A patient-controlled device prepared with 10 mcg/ ml fentanyl will be attached to all patients with a protocol including 10 mcg bolus without infusion dose, 10 min lockout time, and 4-hour limit. If the NRS score is ≥ 4, 0.5 mg kg-1 iv meperidine will be administered as a rescue analgesic. Postoperative patient evaluation will be performed by an anesthesiologist blinded to the procedure.
Study NCT04812236 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Wulingsan single decoction granules
Description: Wulingsan single decoction granules, the prescription is Alisma, Polyporus, Atractylodes, Poria, Guizhi. Oral, 2 times a day, 2 sachets each time, rinsed with warm water
Study NCT05004909 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 0.05% Tretinoin
Description: Topical 0.05% tretinoin cream applied daily every night by the subjects according to assigned randomization
Study NCT04812236 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Wulingsan co-decoction granules
Description: Wulingsan co-decoction granules, the prescription is Alisma, Polyporus, Atractylodes, Poria, Guizhi. Oral, 2 times a day, 2 sachets each time, rinsed with warm water
Study NCT04812236 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Wuling Powder
Description: Wuling powder is composed of Alisma, Polyporus, Atractylodes, Poria, Guizhi. 2 times a day, 5g each time, take it with warm water
Study NCT04812236 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Wulingsan granule simulant
Description: Wulingsan granule simulant, the prescription is Alisma, Polyporus, Atractylodes, Poria, Guizhi. Oral, 2 times a day, 2 sachets each time, rinsed with warm water
Study NCT00992615 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: prostate biopsy
Description: prostate cores - 12 or 20
Study NCT00992615 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: prostate biopsy
Description: prostate cores - 12 or 20
Study NCT06150417 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT)
Description: Standard androgen deprivation therapy (ADT) will be administered at the discretion of treating physician.
Study NCT06150417 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Androgen deprivation therapy (ADT)
Description: Standard androgen deprivation therapy (ADT) will be administered at the discretion of treating physician.
Study NCT06150417 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Androgen receptor signaling inhibitor (ARSI)
Description: Standard androgen receptor signaling inhibitors (ARSI) will be administered at the discretion of the treating physician.
Study NCT06150417 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Androgen receptor signaling inhibitor (ARSI)
Description: Standard androgen receptor signaling inhibitors (ARSI) will be administered at the discretion of the treating physician.
Study NCT05451160 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: steep pulse therapy system
Description: The steep pulse therapy system is produced by Zhejiang CuraWay Medical Technology Co., Ltd. for liver tumor ablation
Study NCT05451160 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: RF Ablation System
Description: RF Ablation System
Study NCT06150417 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Local Therapy: Radical Prostatectomy (RP) or Radiotherapy (RT)
Description: Local therapy will either be radiotherapy (RT) or radical prostatectomy (RP).~* Prostate +/- pelvic nodal radiation~* Radical prostatectomy + pelvic lymph node dissection
Study NCT06150417 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Local Therapy: Radical Prostatectomy (RP) or Radiotherapy (RT)
Description: Local therapy will either be radiotherapy (RT) or radical prostatectomy (RP).~* Prostate +/- pelvic nodal radiation~* Radical prostatectomy + pelvic lymph node dissection
Study NCT06150417 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Metastasis directed radiotherapy (MDRT)
Description: In participants randomized to the MDRT arm, MDRT to all lesions will be performed by the end of Week 24. Selection of a particular regimen (the dose and fractionation) will based on the size and location of the participant's metastatic site and the surrounding normal tissue constraints.
Study NCT05690230 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual reality
Description: Patients will be provided with a wireless virtual reality headset that contains a guided meditation application. The application allows users to select their preferred music, visual setting, and a topic for meditation.
Study NCT05690230 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Environmental changes
Description: A nature themed wall mural decal will be installed in the procedure room and the in-room computer will play music from Pandora. A selection of suggested stations will be provided, with the option for outside selections.
Study NCT04359784 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Anakinra
Description: Given IV (previously SC)
Study NCT04359784 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: X-Ray Imaging
Description: Undergo x-ray
Study NCT04359784 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET/CT
Study NCT05357586 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Unified Protocol for Transdiagnostic Treatment of Emotional Disorders
Description: The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders is a manualized, evidence-based form of cognitive behavioral therapy aimed at targeting emotion regulation processes that underlie common forms of emotional disorders such as anxiety, depression, and commonly co-occurring mental health challenges.
Study NCT05162833 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TheraNova Neuromodulation Device
Description: TENS device
Study NCT05212623 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: quadrivalent influenza split vaccine
Description: This vaccine is produced by Changchun Sponsor Institute of Biological Products Co., Ltd. Subjects will receive two doses of quadrivalent influenza vaccine administered 4 weeks apart by intramuscular injection
Study NCT05212623 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Influenza virus split vaccine
Description: This vaccine is produced by Changchun Sponsor Institute of Biological Products Co., Ltd. Subjects will receive two doses of quadrivalent influenza vaccine administered 4 weeks apart by intramuscular injection
Study NCT04359784 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo PET/CT or CT
Study NCT04359784 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Aspiration
Description: Undergo BMA
Study NCT04359784 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Biopsy
Description: Undergo bone marrow biopsy
Study NCT04359784 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lumbar Puncture
Description: Undergo lumbar puncture
Study NCT04359784 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT05212623 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Influenza virus split vaccine
Description: This vaccine is produced by Changchun Sponsor Institute of Biological Products Co., Ltd. Subjects will receive two doses of quadrivalent influenza vaccine administered 4 weeks apart by intramuscular injection.
Study NCT05516264 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Dog visits/control visits
Description: See arm description above
Study NCT05516264 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Control visits/dog visits
Description: See arm description above
Study NCT04493229 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxytocin
Description: IM Oxytocin
Study NCT04493229 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Placebo IM
Study NCT04726124 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Microwave Ablation Therapeutic Apparatus
Description: The selected and qualified subjects with primary lower extremity varicose veins were randomly treated with microwave ablation equipment or laser treatment equipment. Subjects in the two groups were returned to the hospital for follow-up at 7 days, 3 months, 6 months, 12 months after surgery, respectively, for ultrasound examination and questionnaire evaluation, medication status and adverse events were recorded, and target lesion closure rate and subject satisfaction were evaluated.
Study NCT04849260 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pexa-Vec combined with ZKAB001
Description: 1. Intratumoral injection of low dose Pexa-Vec (3×10\^8pfu) combined with intravenous of ZKAB001 (5mg/kg), every 2 weeks as one cycle.~2. Intratumoral injection of high dose Pexa-Vec (1×10\^9pfu) combined with intravenous of ZKAB001 (5mg/kg), every 2 weeks as one cycle.
Study NCT04849260 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: ZKAB001 monotherapy
Description: ZKAB001 monotherapy
Study NCT05261594 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Caffeine
Description: Caffeine capsule 150 mg, oral intake
Study NCT05261594 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Placebo
Description: Placebo capsule, oral intake
Study NCT04825379 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: bioactive composite
Description: Cention N
Study NCT03650101 — intervention group
Intervention type: PROCEDURE
Intervention: ETV/CPC
Description: The Endoscopic Third Ventriculostomy/Choroid Plexus Cauterization (ETV/CPC) will comprise a standard frontal approach with flexible endoscopy.
Study NCT04825379 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: posterior composite
Description: G-ænial Posterior
Study NCT06507345 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Opioid Analgesia (OA) [Multimodal analgesia including opioid drugs]
Description: In line with current standard care, discharge prescriptions for this group will include around-the-clock non-opioid analgesics (acetaminophen and/or NSAIDs given at regularly scheduled intervals) and opioid tablets 'as needed' for breakthrough pain (i.e., pain that erupts while patients are already taking analgesics). Non-pharmacological pain interventions (i.e., icepacks, music, meditation.) may be recommended by some surgeons as part of standard practice. Given the pragmatic nature of the trial, the specific around-the-clock analgesia and rescue opioid regimens and other non-pharmacological interventions will be determined by the patient's surgeon discretion considering the breast procedure undertaken, co-morbidities, and patient preference.
Study NCT06507345 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Opioid-Free Analgesia (OFA) [Multimodal analgesia not including opioid drugs]
Description: Discharge prescriptions for this group will include around-the-clock non-opioid analgesics (acetaminophen and/or NSAIDs). In case of breakthrough pain, rescue analgesia may be provided by (1) using evidence-based non-pharmacological pain interventions (i.e., icepacks, music, and meditation), (2) adding non-opioid drugs not included in the initial regimen, or (3) switching drugs targeting individual variances in analgesia response. The specific around-the-clock and rescue OFA regimens will be determined by the patient's surgeon considering the type of procedure, co-morbidities, and patient preference.
Study NCT04922814 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: muscle relaxation
Description: They will receive muscle relaxation treatment for at least 48 hours. Cisatracurium will be given. Short term infusions up to 24 hours will be given in a dose rate of 2-3 mic/Kg/min followed by intervallic shots of 2-5 mg.
Study NCT06231251 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: upper gastrointestinal endoscopy
Description: reduction of ghrelin rich gastric mucosa with band ligation or argon plasma
Study NCT05444829 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: specific screw holes locating surgical guide and pre-bent plates
Description: Put the specific screw holes locating device in place and drill the screw holes, remove the screw holes locating device and mobilize the segments then apply the pre-bent plates and fix it with screw for passive reduction of the segments. Then suture the mentalis muscle then the mucosa.
Study NCT05444829 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: classical reduction and internal fixation.
Description: mobilize the broken segment first, Arch bar was made to achieve proper occlusion put the compression plate on the inferior border and remove it for further bending using plate pliers for further accommodation of the plate on the inferior border the fix it in place using compression and tension plate.
Study NCT04801823 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Home introduction
Description: Cautious, graded introduction of individual tree nuts
Study NCT04801823 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multi Nut oral food challenge
Description: In hospital multi nut oral food challenge (almond, cashew, hazelnut, walnut)
Study NCT05685511 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Activation
Description: The behavioral intervention will consist of behavioral activation (BA), the basic premise of which is to help people with mental health problems to engage in activities that are reinforcing or meaningful and guided by their personal values
Study NCT05685511 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Medication Optimization
Description: Medication optimization consists of a simple set of principles: reconcile patient's medications, identify the patient's likely need for, and interest in, a medication adjustment, make the adjustment, and assess the response to that adjustment.
Study NCT04932694 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Core stabilization training
Description: Exercise training will be given to the participants in the study group in the form of core training exercises for 8 weeks.
Study NCT05183594 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: TSupport (a Traditional Chinese Medicine)
Description: TSupport is made up of 11 Chinese medicinal herbs.
Study NCT05375838 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1073
Description: Sterile liquid for injection
Study NCT05375838 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1010
Description: Sterile liquid for injection
Study NCT05375838 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1273
Description: Sterile liquid for injection
Study NCT05375838 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 0.9% sodium chloride (normal saline) injection
Study NCT05367921 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Measurement of compartment compressibility
Description: Application of the CPM#1 device for compartment compressibility ratio measurement - 4 measurements on both legs of each healthy volunteer will be performed
Study NCT05049122 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dupilumab SAR231893
Description: Pharmaceutical form: solution for injection Route of administration: subcutaneous (SC)
Study NCT04926870 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: picture archiving and communication system
Description: PACS administration during teaching
Study NCT04926870 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: traditional
Description: Clinical experience administration during teaching without PACS
Study NCT06135766 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: A Lust for Life
Description: A Lust for Life (ALFL) is a universal teacher-led programme which aims to build resilience, increase wellbeing, and enhance emotional literacy of 8-13 year old school children. The programme spans ten 40-minute classes. The ALFL curriculum draws on multiple sources including contemporary positive psychology; traditional, second, and third wave cognitive behaviour therapy (CBT); and developmental, educational, and health psychology. In ALFL children learn the following specific self-regulation skills: naming and rating the intensity of emotions; linking thoughts, feelings and actions; mindfulness; breathing exercises; visualization exercises; progressive muscle relaxation; positive self-talk (gratitude, optimism, and cognitive restructuring); obtaining social support from adults and peers; assertiveness; managing bullying; and using the internet safely. Skills are learned through didactic instruction, video modelling, in-class experiential exercises, and homework practice.
Study NCT06135766 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Waiting List Control
Description: Control group placed on a 12-week waiting list for the A Lust for Life (ALFL) programme.
Study NCT06460935 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: sexual health training
Description: The 20-hour sexual health training will be given online for 5 weeks. Case discussions using the Plissit Model will be held in the training content.
Study NCT04729010 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Acupuncture to treat anxiety in Parkinson disease
Description: Subjects will be randomized in a 1:1 ratio to receive sham acupuncture.
Study NCT06114082 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: IDA-TACE
Description: Stable chemoemulsion will be produced by dissolving 10 mg of idarubicin powder (Zavedos; Pfizer, New York, NY, USA) in 2.5 mL of an iodinated contrast agent. This solution will then be mixed with 10 mL of iodized oil (Lipiodol Ultrafluid; Guerbet, Villepinte, France) using a three-way stopcock. This chemoemulsion will be prepared in aliquots (0.8 mL of chemoemulsion in each 1 mL syringe) and injected until the embolization endpoint is achieved.
Study NCT06114082 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: DOX-TACE
Description: Stable chemoemulsion will be produced by dissolving 50 mg of doxorubicin powder (Adriamycin RDF; Ildong Pharmaceutical, Seoul, Republic of Korea) in 2.5 mL of an iodinated contrast agent. This solution will then be mixed with 10 mL of iodized oil (Lipiodol Ultrafluid; Guerbet, Villepinte, France) using a three-way stopcock. This chemoemulsion will be prepared in aliquots (0.8 mL of chemoemulsion in each 1 mL syringe) and injected until the embolization endpoint is achieved.
Study NCT05299723 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BLT Intervention
Description: BLT will be administered via a Luminette 3 light therapy visor. The Luminette 3 is a visor worn above the eyes containing light emitting diode (LEDs) emitting a blue-enriched white light reflecting to the retina at 1,000 lux via a holographic system in order to ensure correct penetration into the eye without impeding vision. This range of light and intensity is sufficient to synchronize the circadian clock.
Study NCT05299723 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BLB Intervention
Description: BLB will be administered via orange lenses that filter out short-wavelength blue light, while allowing the other visible spectrum light to pass. The BLB lenses result in a reduction in melanopic irradiance (i.e., the light that affects sleep) of about 85%. The BLB lenses only make the overall light environment about 30% dimmer. Therefore, the BLB lenses are effective in blocking out most of the blue light in the visible environment that impacts sleep, but do not result in drastic overall dimming/darkening of the light environment.
Study NCT05299723 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep Hygiene Education
Description: The sleep hygiene education will consist of watching a sleep education video (background on the regulation of sleep, the impacts of insufficient sleep on mental and physical health, etc.) and a sleep hygiene video (providing overview of sleep hygiene approaches).
Study NCT05299723 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Sleep Hygiene Education
Description: The sleep hygiene education will consist of watching a sleep education video (background on the regulation of sleep, the impacts of insufficient sleep on mental and physical health, etc.) and a sleep hygiene video (providing overview of sleep hygiene approaches).
Study NCT06195813 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Asparagus capsule
Description: Asparagus capsule is categorized as dietary supplement.
Study NCT06195813 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo capsule
Description: Placebo capsule is categorized as other.
Study NCT05996315 — intervention group
Intervention type: OTHER
Intervention: Hematoma block
Description: A patient who presents to the emergency department with a suspected distal end radius fracture , will be sent for an x-ray. If the X ray-shows a distal end radius fracture a decision to give hematoma block will be taken as per the choice of the treating physician. Patients who do not meet the exclusion criteria are excluded from the study at this phase.